================================================================================

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

--------------------

FORM 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2006

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

COMMISSION FILE NUMBER 1-10235

IDEX CORPORATION
(Exact Name of Registrant as Specified in its Charter)

DELAWARE 36-3555336
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)

630 DUNDEE ROAD, NORTHBROOK, ILLINOIS 60062
(Address of principal executive offices) (Zip Code)

Registrant's telephone number: (847) 498-7070

Indicate by check mark whether the registrant: (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.

Yes [X] No [ ]

Indicate by check mark whether the registrant is a large accelerated
filer, an accelerated filer or a non-accelerated filer.

Large accelerated filer [X] Accelerated filer [ ] Non-accelerated filer [ ]

Indicate by check mark whether the registrant is a shell company (as
defined in Rule 12b-2 of the Exchange Act).

Yes [ ] No [X]

Number of shares of common stock of IDEX Corporation outstanding as of
July 31, 2006: 53,462,780 (net of treasury shares).

================================================================================

TABLE OF CONTENTS

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements. 1

Consolidated Balance Sheets 1
Consolidated Statements of Operations 2
Consolidated Shareholders' Equity 3
Consolidated Cash Flows 4
Notes to Consolidated Financial Statements 5

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations. 14

Cautionary Statement Under the Private Securities Litigation Reform Act 14
Historical Overview and Outlook 15
Results of Operations 16
Liquidity and Capital Resources 20

Item 3. Quantitative and Qualitative Disclosures About Market Risk. 21

Item 4. Controls and Procedures. 21

PART II. OTHER INFORMATION

Item 1. Legal Proceedings. 21

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds. 22

Item 4. Submission of Matters to a vote of Security Holders. 22

Item 5. Other Information. 23

Item 6. Exhibits. 23

Signatures 23

Exhibit Index 24

Certifications 25

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS.

IDEX CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(IN THOUSANDS EXCEPT SHARE AND PER SHARE AMOUNTS)
(UNAUDITED)

JUNE 30, DECEMBER 31,
2006 2005
-------- ------------

ASSETS
Current assets
Cash and cash equivalents ...................................................... $ 51,052 $ 77,202
Receivables, less allowance for doubtful accounts of $4,368 at June 30, 2006
and $3,687 at December 31, 2005 ............................................ 154,588 129,816
Inventories ................................................................... 138,204 123,631
Assets held for sale .......................................................... 9,109 9,138
Other current assets .......................................................... 15,189 11,006
----------- -----------
Total current assets ....................................................... 368,142 350,793
Property, plant and equipment -- net ............................................... 154,675 142,663
Goodwill ........................................................................... 778,744 691,399
Intangible assets -- net ........................................................... 54,639 28,615

Other noncurrent assets ............................................................ 30,314 30,710
----------- -----------
Total assets ............................................................... $ 1,386,514 $ 1,244,180
=========== ===========

LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities
Trade accounts payable ........................................................ $ 78,848 $ 67,047
Accrued expenses .............................................................. 91,455 72,481
Short-term borrowings ......................................................... 7,773 3,144
Liabilities held for sale ..................................................... 3,465 4,303
Dividends payable ............................................................. 7,999 6,321
----------- -----------
Total current liabilities .................................................. 189,540 153,296
Long-term borrowings ............................................................... 190,998 156,899
Other noncurrent liabilities ....................................................... 93,231 110,975
----------- -----------

Total liabilities .......................................................... 473,769 421,170
----------- -----------

Shareholders' equity
Common stock:
Authorized: 150,000,000 shares, $.01 per share par value
Issued: 53,502,676 shares at June 30, 2006 and 52,857,059 shares at
December 31, 2005 ....................................................... 535 529
Additional paid-in capital .................................................... 316,409 290,428
Retained earnings ............................................................. 573,060 524,035
Minimum pension liability adjustment .......................................... (5,884) (5,884)
Cumulative translation adjustment ............................................. 42,320 25,160
Treasury stock at cost: 73,181 shares at June 30, 2006 and 63,318 shares at
December 31, 2005 .......................................................... (2,866) (2,361)
Unearned stock compensation ................................................... (10,829) (8,897)
----------- -----------
Total shareholders' equity ................................................. 912,745 823,010
----------- -----------
Total liabilities and shareholders' equity ................................. $ 1,386,514 $ 1,244,180
=========== ===========

See Notes to Consolidated Financial Statements.

-1-

IDEX CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(IN THOUSANDS EXCEPT PER SHARE AMOUNTS)
(UNAUDITED)

SECOND QUARTER SIX MONTHS
ENDED JUNE 30, ENDED JUNE 30,
--------------------- ---------------------
2006 2005 2006 2005
-------- -------- -------- --------

Net sales ........................................... $297,169 $264,949 $564,036 $510,087
Cost of sales ....................................... 174,156 155,370 330,896 300,687
-------- -------- -------- --------
Gross profit ........................................ 123,013 109,579 233,140 209,400
Selling, general and administrative expenses ........ 67,400 61,989 130,264 121,715
-------- -------- -------- --------
Operating income .................................... 55,613 47,590 102,876 87,685
Other income -- net ................................. 255 245 262 337
Interest expense .................................... 4,074 3,806 7,028 7,685
-------- -------- -------- --------
Income from continuing operations before income taxes 51,794 44,029 96,110 80,337
Provision for income taxes .......................... 17,382 15,420 32,416 28,486
-------- -------- -------- --------
Income from continuing operations ................... 34,412 28,609 63,694 51,851
Income from discontinued operations, net of tax ..... 544 324 1,339 727
-------- -------- -------- --------
Net income .......................................... $ 34,956 $ 28,933 $ 65,033 $ 52,578
======== ======== ======== ========

Basic earnings per common share:
Continuing operations ............................... $ .65 $ .56 $ 1.21 $ 1.02
Discontinued operations ............................. .01 .01 .02 .01
-------- -------- -------- --------
Net income .......................................... $ .66 $ .57 $ 1.23 $ 1.03
======== ======== ======== ========

Diluted earnings per common share:
Continuing operations ............................... $ .64 $ .54 $ 1.18 $ .99
Discontinued operations ............................. .01 .01 .03 .01
-------- -------- -------- --------
Net income .......................................... $ .65 $ .55 $ 1.21 $ 1.00
======== ======== ======== ========

Share data:
Basic weighted average common shares outstanding .... 53,014 50,963 52,825 50,821
Diluted weighted average common shares outstanding .. 54,029 52,641 53,952 52,484

See Notes to Consolidated Financial Statements.

-2-

IDEX CORPORATION AND SUBSIDIARIES
CONSOLIDATED SHAREHOLDERS' EQUITY
(IN THOUSANDS EXCEPT SHARE AND PER SHARE AMOUNTS)
(UNAUDITED)

COMMON
STOCK & MINIMUM
ADDITIONAL PENSION CUMULATIVE UNEARNED TOTAL
PAID-IN RETAINED LIABILITY TRANSLATION TREASURY STOCK SHAREHOLDERS'
CAPITAL EARNINGS ADJUSTMENT ADJUSTMENT STOCK COMPENSATION EQUITY
----------- -------- ---------- ----------- -------- ------------ -------------

Balance, December 31, 2005... $290,957 $524,035 $(5,884) $25,160 $(2,361) $(8,897) $823,010
Net income... 65,033 65,033
Other comprehensive income
Cumulative translation adjustment 17,160 17,160
--------
Other comprehensive income... 17,160
--------
Comprehensive income......... 82,193
--------
Issuance of 574,757 shares of
common stock from exercise of
stock options and deferred
compensation plans... 22,454 22,454
Issuance of restricted stock... 3,533 (3,533) --
Amortization of restricted stock.... 1,601 1,601
Restricted shares surrendered for
tax withholdings ........ (505) (505)
Cash dividends declared - $.30 per
common share outstanding... (16,008) (16,008)
-------- -------- --------- ------- -------- -------- --------
Balance, June 30, 2006...... $316,944 $573,060 $(5,884) $42,320 $(2,866) $(10,829) $912,745
======== ======== ========= ======= ======= ======== ========

</Table>

See Notes to Consolidated Financial Statements.

-3-

IDEX CORPORATION AND SUBSIDIARIES
CONSOLIDATED CASH FLOWS
(IN THOUSANDS)
(UNAUDITED)

SIX MONTHS
ENDED JUNE 30,
------------------------
2006 2005
--------- ---------

Cash flows from operating activities of continuing operations
Net income ...................................................................... $ 65,033 $ 52,578
Adjustments to reconcile net income to net cash provided by operating activities:
Earnings from discontinued operations ....................................... (1,339) (727)
Depreciation and amortization ............................................... 12,871 13,369
Amortization of intangible assets ........................................... 1,270 365
Amortization of debt issuance expenses ...................................... 228 288
Gain on sale of fixed assets ................................................ (810) --
Stock-based compensation expense ............................................ 5,678 1,532
Deferred income taxes ....................................................... (20,263) (1,146)
Excess tax benefit from stock-based compensation ............................ (4,633) --
Changes in (net of the effect from acquisitions):
Receivables ............................................................ (13,065) (29,418)
Inventories ............................................................ (775) (3,480)
Trade accounts payable ................................................. 7,134 11,147
Accrued expenses ....................................................... 20,099 4,765
Other -- net ................................................................ (3,196) 2,465
--------- ---------
Net cash flows from operating activities of continuing operations ..... 68,232 51,738

Cash flows from investing activities of continuing operations
Additions to property, plant and equipment .................................. (9,703) (11,702)
Acquisition of businesses, net of cash acquired ............................. (120,186) (425)
Proceeds from fixed assets disposals ........................................ 1,048 29
Other ....................................................................... (800) --
--------- ---------
Net cash flows from investing activities of continuing operations ..... (129,641) (12,098)

Cash flows from financing activities of continuing operations
Borrowings under credit facilities for acquisitions ......................... 44,000 425
Net repayments under credit facilities ...................................... (12,889) (34,054)
Net repayments of other long-term debt ...................................... -- (647)
Dividends paid .............................................................. (14,330) (12,218)
Distributions from discontinued operations .................................. 530 1,299
Proceeds from stock option exercises ........................................ 13,343 8,672
Excess tax benefit from stock-based compensation ............................ 4,633 --
Other -- net ................................................................ (504) (1,601)
--------- ---------
Net cash flows from financing activities of continuing operations ..... 34,783 (38,124)

Cash flows from discontinued operations
Net cash provided by operating activities of discontinued operations ....... 772 1,460
Net cash used in investing activities of discontinued operations ........... (321) (165)
Net cash used in financing activities of discontinued operations ........... (530) (1,299)
--------- ---------
Net cash flows from discontinued operations ........................... (79) (4)

Effect of exchange rate changes on cash and cash equivalents .................... 476 --
--------- ---------

Net (decrease) increase in cash ................................................. (26,229) 1,512
Cash and cash equivalents at beginning of year .................................. 77,290 7,274
--------- ---------
Cash and cash equivalents at end of period ...................................... $ 51,061 $ 8,786
========= =========

Less-cash, end of period-discontinued operations ................................ 9 9
--------- ---------
Cash and cash equivalents at end of period-continuing operations ................ $ 51,052 $ 8,777
========= =========

SUPPLEMENTAL CASH FLOW INFORMATION
Cash paid for:
Interest .................................................................... $ 6,458 $ 7,452
Income taxes ................................................................ 31,419 17,169
Significant non-cash activities:
Issuance of restricted stock ................................................ $ 3,533 $ 6,669
Debt acquired with acquisition of business .................................. 7,120 --

See Notes to Consolidated Financial Statements.

-4

IDEX CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(IN THOUSANDS EXCEPT PER SHARE AMOUNTS)
(UNAUDITED)

1. BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

The consolidated financial statements of IDEX Corporation ("IDEX" or the
"Company") have been prepared in accordance with the instructions to Form 10-Q
under the Securities Exchange Act of 1934, as amended. The statements are
unaudited but include all adjustments, consisting only of recurring items,
except as noted, which the Company considers necessary for a fair presentation
of the information set forth herein. The results of operations for the three and
six months ended June 30, 2006 are not necessarily indicative of the results to
be expected for the entire year.

The consolidated financial statements and Management's Discussion and
Analysis of Financial Condition and Results of Operations should be read in
conjunction with the Company's Annual Report on Form 10-K for the fiscal year
ended December 31, 2005.

Stock-Based Compensation

Effective January 1, 2006, IDEX adopted the fair value recognition
provisions of Statement of Financial Accounting Standards ("SFAS") No. 123(R),
"Share-Based Payment," using the modified prospective transition method and
therefore has not restated results for prior periods. Under this transition
method, stock-based compensation expense for the three and six months ended June
30, 2006 includes compensation expense for all stock-based compensation awards
granted prior to, but not yet vested as of December 31, 2005, based on the grant
date fair value estimated in accordance with the original provisions of SFAS No.
123, "Accounting for Stock-Based Compensation." Stock-based compensation expense
for all stock-based compensation awards granted after December 31, 2005 is based
on the grant-date fair value estimated in accordance with the provisions of SFAS
No. 123(R). IDEX recognizes these compensation costs on a straight-line basis
over the requisite service period of the award, which is generally the option
vesting period of four years. Prior to the adoption of SFAS No. 123(R), IDEX
recognized stock-based compensation expense in accordance with Accounting
Principles Bulletin ("APB") Opinion No. 25, "Accounting for Stock Issued to
Employees." In March 2005, the Securities and Exchange Commission ("SEC") issued
Staff Accounting Bulletin ("SAB") No. 107 regarding the SEC's interpretation of
SFAS No. 123(R) and the valuation of share-based payments for public companies.
IDEX has applied the provisions of SAB No. 107 in its adoption of SFAS No.
123(R). See Note 10 to the Consolidated Financial Statements for a further
discussion on stock-based compensation.

Uncertainty in Income Taxes

In July 2006, the Financial Accounting Standards Board ("FASB") issued FASB
Interpretation ("FIN") 48, "Accounting for Uncertainty in Income Taxes--an
interpretation of FASB Statement No. 109." This interpretation clarifies the
accounting for uncertainty in income taxes recognized in an entity's financial
statements in accordance with SFAS No. 109, "Accounting for Income Taxes." It
prescribes a recognition threshold and measurement attribute for financial
statement disclosure of tax positions taken or expected to be taken on a tax
return. This interpretation is effective for fiscal years beginning after
December 15, 2006. IDEX will be required to adopt this interpretation in the
first quarter of 2007. Management is currently evaluating the requirements of
FIN 48 and has not yet determined the impact on the consolidated financial
statements.

2. ACQUISITIONS

On January 12, 2006, the Company acquired the assets of Airshore
International ("Airshore"), based in British Columbia, Canada. Airshore has
annual sales of approximately $5 million and provides stabilization struts for
collapsed buildings and vehicles, high and low pressure lifting bags and
forcible entry tools for the fire and rescue markets. Airshore operates as part
of our Hale business unit within the Fire & Safety/Diversified Products segment.
IDEX acquired Airshore for a purchase price of $12.6 million, consisting
entirely of cash.

-5-

IDEX CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
(IN THOUSANDS EXCEPT PER SHARE AMOUNTS)
(UNAUDITED)

On February 28, 2006, the Company acquired JUN-AIR International A/S
("JUN-AIR"), based in Norresundby, Denmark. JUN-AIR has annual sales of
approximately $22 million and is a provider of low decibal, ultra quiet vacuum
compressors suitable to medical, dental and laboratory applications. JUN-AIR
operates as part of our Gast business unit within IDEX's Health & Science
Technologies segment. IDEX acquired JUN-AIR for an aggregate purchase price of
$22.4 million, consisting of cash consideration of $15.3 million and acquired
debt of approximately $7.1 million.

On May 2, 2006, the Company acquired the assets of Eastern Plastics, Inc.
("EPI"), a provider of high-precision integrated fluidics and associated
engineered plastics solutions. Based in Bristol, Connecticut, with revenues of
approximately $30 million, EPI's products are used in a broad set of end markets
including medical diagnostics, analytical instrumentation, and laboratory
automation. IDEX acquired EPI for a purchase price of $92.3 million, consisting
entirely of cash. EPI is being operated as a stand-alone business as part of the
Company's Health & Science Technologies segment.

The purchase price for Airshore, JUN-AIR and EPI, including transaction
costs, has been allocated to the assets acquired and liabilities assumed based
on estimated fair values at the date of the acquisitions. The purchase price
allocation is preliminary and further refinements may be necessary.

The results of operations for these acquisitions have been included within
the financial results from the date of the respective acquisitions. The Company
does not consider any of the acquisitions, individually or in aggregate, to be
material to its results of operations for any of the periods presented.

3. DISCONTINUED OPERATIONS

During the second quarter of 2006, the Company determined that Lubriquip,
its lubricant dispensing business operating as part of IDEX's Dispensing
Equipment segment, met the criteria to be classified as a discontinued
operation. Subsequently, on July 11, 2006, the Company sold Lubriquip to Graco
Inc. The assets and liabilities of Lubriquip have been classified as current
assets and liabilities held for sale. The financial results of Lubriquip
included in discontinued operations were as follows:

SECOND QUARTER SIX MONTHS
ENDED JUNE 30, ENDED JUNE 30,
--------------------- -------------------
2006 2005 2006 2005
-------- -------- ------- -------

Revenue .................................................... $ 7,246 $ 6,809 $15,449 $13,729
======= ======= ======= =======

Income from discontinued operations before income taxes..... 871 542 2,128 1,180
Income tax provision ....................................... 327 218 789 453
------- ------- ------- -------
Income from discontinued operations ........................ $ 544 $ 324 $ 1,339 $ 727
======= ======= ======= =======

-6-

IDEX CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
(IN THOUSANDS EXCEPT PER SHARE AMOUNTS)
(UNAUDITED)

Total assets and liabilities of Lubriquip held for sale at June 30, 2006
and December 31, 2005 were as follows:

JUNE 30, DECEMBER 31,
2006 2005
------- ------------

Cash and cash equivalents ................................................................. $ 9 $ 88

Receivables, net .......................................................................... 2,855 2,727
Inventory, net ............................................................................ 2,923 2,945
Other current assets ...................................................................... 80 85

Property, plant and equipment, net equivalents ............................................ 2,771 2,822
Intangibles, net assets ................................................................... 471 471
------ ------
Total assets ............................................................................. $9,109 $9,138
====== ======

Accounts payable ......................................................................... $2,027 $2,426
Other liabilities ........................................................................ 1,438 1,877
------ ------
Total liabilities ........................................................................ $3,465 $4,303
====== ======

4. BUSINESS SEGMENTS

Effective in the second quarter of 2006, IDEX changed its reporting
segments based on recent organizational and structural changes from three to
four reportable segments. The new business structure reflects a more focused
market strategy across all businesses. Through this new structure, the Company
will be better positioned to address emerging customer needs in industrial fluid
and metering technologies, health and science instrumentation and equipment,
dispensing, and fire and safety. The addition of a fourth segment reflects our
evolving capability and content for applied health and science technologies.
Under the new reporting structure, the Fluid & Metering Technologies segment
will consist of the following IDEX business units: Liquid Controls, Pulsafeeder,
Viking, Warren Rupp and Versa-Matic. The Health & Science Technologies segment
will include Gast Manufacturing, Micropump, Rheodyne, Scivex and
recently-acquired EPI. The Dispensing Equipment segment will consist of FAST and
Fluid Management. The Fire & Safety/Diversified Products segment will include
the Company's Hale Products' fire suppression and rescue tools businesses, as
well as its BAND-IT engineered clamping business. Historical business segment
information has been updated to reflect this change in reporting segments.

Information on IDEX's business segments from continuing operations is
presented below, based on the nature of products and services offered. IDEX
evaluates performance based on several factors, of which operating income is the
primary financial measure. Intersegment sales are accounted for at fair value as
if the sales were to third parties.

-7-

IDEX CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
(IN THOUSANDS EXCEPT PER SHARE AMOUNTS)
(UNAUDITED)

SECOND QUARTER SIX MONTHS
ENDED JUNE 30, ENDED JUNE 30,
------------------------ ------------------------
2006 2005 2006 2005
--------- --------- --------- ---------

Net sales
Fluid & Metering Technologies:
External customers ...................... $ 107,985 $ 98,322 $ 210,102 $ 191,560
Intersegment sales ...................... 452 471 734 704
--------- --------- --------- ---------
Total group sales ..................... 108,437 98,793 210,836 192,264
--------- --------- --------- ---------
Health & Science Technologies:
External customers ...................... 80,218 59,122 142,346 111,045
Intersegment sales ...................... 1,081 419 1,974 1,417
--------- --------- --------- ---------
Total group sales ..................... 81,299 59,541 144,320 112,462
--------- --------- --------- ---------
Dispensing Equipment:
External customers ...................... 44,415 46,308 85,822 90,715
Intersegment sales ...................... -- -- 1 --
--------- --------- --------- ---------
Total group sales ..................... 44,415 46,308 85,823 90,715
--------- --------- --------- ---------
Fire & Safety/Diversified Products:
External customers ...................... 64,551 61,197 125,766 116,767
Intersegment sales ...................... -- 2 1 4
--------- --------- --------- ---------
Total group sales ..................... 64,551 61,199 125,767 116,771
--------- --------- --------- ---------
Intersegment elimination .................. (1,533) (892) (2,710) (2,125)
--------- --------- --------- ---------
Total net sales ....................... $ 297,169 $ 264,949 $ 564,036 $ 510,087
========= ========= ========= =========

Operating income
Fluid & Metering Technologies ............. $ 21,275 $ 18,244 $ 40,519 $ 33,522
Health & Science Technologies ............. 14,513 10,115 26,793 19,117
Dispensing Equipment ...................... 11,689 12,870 22,019 23,943
Fire & Safety/Diversified Products ........ 16,266 13,964 29,921 25,502
Corporate office and other ................ (8,130) (7,603) (16,376) (14,399)
--------- --------- --------- ---------
Total operating income ............... $ 55,613 $ 47,590 $ 102,876 $ 87,685
========= ========= ========= =========

5. EARNINGS PER COMMON SHARE

Earnings per common share ("EPS") are computed by dividing net income by
the weighted average number of shares of common stock (basic) plus common stock
equivalents outstanding (diluted) during the period. Common stock equivalents
consist of stock options, which have been included in the calculation of
weighted average shares outstanding using the treasury stock method, unvested
restricted shares, and shares issuable in connection with certain deferred
compensation agreements ("DCUs"). Basic weighted average shares reconciles to
diluted weighted average shares as follows:

SECOND QUARTER SIX MONTHS
ENDED JUNE 30, ENDED JUNE 30,
------------------ -----------------
2006 2005 2006 2005
------ ------- ------ ------

Basic weighted average common shares outstanding .................. 53,014 50,963 52,825 50,821
Dilutive effect of stock options, unvested restricted shares,
and DCUs .......................................................... 1,015 1,678 1,127 1,663
------ ------ ------ ------
Diluted weighted average common shares outstanding ................ 54,029 52,641 53,952 52,484
====== ====== ====== ======

-8-

IDEX CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
(IN THOUSANDS EXCEPT PER SHARE AMOUNTS)
(UNAUDITED)

Options to purchase approximately .9 million and .6 million shares of
common stock as of June 30, 2006 and 2005, respectively, were not included in
the computation of diluted EPS because the exercise price was greater than the
average market price of the Company's common stock and, therefore, the effect of
their inclusion would be antidilutive.

6. INVENTORIES

The components of inventories as of June 30, 2006 and December 31, 2005
were:

JUNE 30, DECEMBER 31,
2006 2005
-------- ------------

Raw materials .......................... $ 53,074 $ 51,257
Work-in-process......................... 15,755 12,749
Finished goods.......................... 69,375 59,625
-------- --------
Total............................... $138,204 $123,631
======== ========

Inventories carried on a LIFO basis amounted to $113,045 and $96,638 at
June 30, 2006 and December 31, 2005, respectively. The excess of current cost
over LIFO inventory value amounted to $1,982 and $1,348 at June 30, 2006 and
December 31, 2005 respectively.

7. GOODWILL AND INTANGIBLE ASSETS

The changes in the carrying amount of goodwill for the six months ended
June 30, 2006, by business group, were as follows:

FLUID & HEALTH & FIRE & SAFETY/
METERING SCIENCE DISPENSING DIVERSIFIED
TECHNOLOGIES TECHNOLOGIES EQUIPMENT PRODUCTS TOTAL
------------ ------------ --------- ------------- -----

Balance at December 31, 2005 ...... $177,223 $261,616 $120,517 $132,043 $691,399
Foreign currency translation ...... 783 362 5,535 4,129 10,809
Acquisitions ...................... -- 68,813 -- 7,723 76,536
-------- -------- -------- -------- --------
Balance at June 30, 2006 .......... $178,006 $330,791 $126,052 $143,895 $778,744
======== ======== ======== ======== ========

During the second quarter, the Company determined that due to changes in
the Company's strategy, certain previously indefinite lived intangible assets
should be considered definite lived assets. Therefore, effective at the
beginning of the second quarter of 2006 the Company began to amortize these
definite lived intangible assets.

The following table provides the gross carrying value and accumulated
amortization for each major class of intangible asset as of June 30, 2006 and
December 31, 2005:

AT JUNE 30, 2006 AT DECEMBER 31, 2005
------------------------------------------------------------------------
GROSS GROSS
CARRYING ACCUMULATED AVERAGE CARRYING ACCUMULATED
AMOUNT AMORTIZATION LIFE AMOUNT AMORTIZATION
-------- ------------ ------- -------- ------------

Amortizable intangible assets:
Patents ....................... $ 8,886 $ (5,103) 11 $ 8,680 $ (4,744)
Trademarks .................... 26,985 (416) 19 23,982 -
Customer intangibles .......... 20,797 (333) 12 - -
Non-compete agreements ........ 1,850 (334) 4 400 (228)
Unpatented technology ......... 1,661 (34) 20 - -
Other ......................... 906 (226) 8 571 (46)
-------- -------- -------- --------
Total ..................... $ 61,085 $ (6,446) $ 33,633 $ (5,018)
======== ======== ======== ========

IDEX CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
(IN THOUSANDS EXCEPT PER SHARE AMOUNTS)
(UNAUDITED)

8. ACCRUED EXPENSES

The components of accrued expenses as of June 30, 2006 and December 31,
2005 were:

JUNE 30, DECEMBER 31,
2006 2005
-------- ------------

Payroll ................................ $23,667 $23,851
Management incentive compensation ...... 8,773 13,109
Income taxes payable ................... 23,018 7,234
Deferred income taxes .................. 1,142 1,142
Insurance .............................. 7,309 6,742
Other .................................. 27,546 20,403
------- -------
Total .............................. $91,455 $72,481
======= =======

9. PREFERRED STOCK

The Company had five million shares of preferred stock authorized but
unissued at June 30, 2006 and December 31, 2005.

10. SHARE-BASED COMPENSATION

As of June 30, 2006, the Company has two stock-based compensation plans for
executives, non-employee directors, and certain key employees which authorize
the granting of stock options, restricted stock, restricted stock units, and
other types of awards consistent with the purpose of the plans. The number of
shares authorized for issuance under the Company's plans as of June 30, 2006
totals 2.3 million, of which .9 million shares were available for future
issuance. Stock options granted under these plans are generally non-qualified,
and are granted with an exercise price equal to the market price of the
Company's stock at the date of grant. Substantially all of the options issued to
employees prior to 2005 become exercisable in five equal installments, while all
options issued to employees in 2005 and after become exercisable in four equal
installments, beginning one year from the date of grant, and generally expire 10
years from the date of grant. Stock options granted to non-employee directors
cliff vest after one or two years. Restricted stock and restricted stock unit
awards generally cliff vest after four years for employees, and two to three
years for non-employee directors.

Prior to January 1, 2006, the Company accounted for its stock-based
compensation using the intrinsic value method of APB Opinion No. 25, "Accounting
for Stock Issued to Employees," and related interpretations. The Company
provided pro forma disclosure in accordance with SFAS No. 148, "Accounting for
Stock-Based Compensation-Transition and Disclosure," as if the fair value method
of SFAS 123 had been applied to stock-based compensation. In accordance with APB
Opinion No. 25, no stock-based compensation cost was reflected in the Company's
prior year net income for grants of stock options to employees because the
Company granted stock options with an exercise price equal to the market value
of the stock on the date of grant. The reported stock-based compensation
expense, net of related tax effects, in prior periods represents the
amortization of restricted stock grants.

-10-

IDEX CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
(IN THOUSANDS EXCEPT PER SHARE AMOUNTS)
(UNAUDITED)

Had the Company used the fair value based accounting method for stock
compensation expense prescribed by SFAS Nos. 123 and 148 for the quarter and six
months ended June 30, 2005, the Company's consolidated net income and net income
per share would have been reduced to the pro-forma amounts illustrated as
follows:

QUARTER ENDED SIX MONTHS ENDED
JUNE 30, 2005 JUNE 30, 2005
------------- ----------------

Income from continuing operations -- as reported $ 28,609 $ 51,851
Add: Total stock-based employee compensation included in reported
income from continuing operations, net of related tax effects 505 974
Deduct: Total stock-based compensation expense determined under fair-value
based method for all awards, net of related tax effects (2,084) (4,484)
---------- ----------

Income from continuing operations -- pro forma $ 27,030 $ 48,341
========== ==========

Income from continuing operations per share:
Basic -- as reported $ 0.56 $ 1.02
Stock -- based compensation 0.03 0.06
---------- ----------
Basic -- pro forma $ 0.53 $ 0.96
========== ==========

Diluted -- as reported $ 0.54 $ .99
Stock-based compensation 0.03 0.06
---------- ----------
Diluted -- pro forma $ 0.51 $ 0.93
========== ==========

Effective January 1, 2006, the Company adopted the fair value recognition
provisions of SFAS No. 123(R) using the modified prospective method, and thus
did not restate any prior period amounts. Under this method, compensation cost
in the three months and six months ending June 30, 2006 include the portion
vesting in the period for (1) all share-based payments granted prior to, but not
vested as of December 31, 2005, based on the grant date fair value estimated
using the Black-Scholes option-pricing model in accordance with the original
provisions of SFAS No. 123 and (2) all share-based payments granted subsequent
to December 31, 2005, based on the grant date fair value estimated using the
Binomial lattice option-pricing model. Weighted average option fair values and
assumptions for the period specified are disclosed in the following table:

QUARTER ENDED JUNE 30, SIX MONTHS ENDED JUNE 30,
----------------------------- -------------------------------
2006 2005 2006 2005
-------------- ---------- ------------- ------------

Weighted average fair value of grants $15.15 $12.33 $15.05 $12.33
Dividend yield 1.16% 1.50% 1.16% 1.50%
Volatility 30.75% 30.00% 30.75% 30.00%
Risk-free interest rate 4.79% - 5.05% 4.3% 4.78% - 5.04% 4.3%
Expected life (in years) 5.0 5.5 4.9 5.5

The assumptions are as follows:

- - The Company estimated volatility using its historical share price
performance over the contractual term of the option.
- - The Company uses historical data to estimate the expected life of the
option. The expected life assumption for the three and six months ended
June 30, 2006 is an output of the Binomial lattice option-pricing model,
which incorporates vesting provisions, rate of voluntary exercise and rate
of post-vesting termination over the contractual life of the option to
define expected employee behavior.
- - The risk-free interest rate is based on the U.S. Treasury yield curve in
effect at the time of grant for periods within the contractual life of the
option. For the three and six months ended June 30, 2006, we present the
range of risk-free one-year forward rates, derived from the U.S. treasury
yield curve, utilized in the Binomial lattice option-pricing model.
- - The expected dividend yield is based on the Company's current dividend
yield as the best estimate of projected dividend yield for periods within
the contractual life of the option.

-11-

IDEX CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
(IN THOUSANDS EXCEPT PER SHARE AMOUNTS)
(UNAUDITED)

Results of prior periods do not reflect any restated amounts and the
Company had no cumulative effect adjustment upon adoption of SFAS No. 123(R)
under the modified prospective method. The Company's policy is to recognize
compensation cost on a straight-line basis over the requisite service period for
the entire award. Additionally, the Company's general policy is to issue new
shares of common stock to satisfy stock option exercises or grants of restricted
shares.

The adoption of SFAS No. 123(R) decreased the Company's reported operating
income and income before income taxes for the three and six months ending June
30, 2006 by $2.3 million and $4.0 million, respectively, and reported net income
by $1.6 million and $2.7 million, respectively. The adoption of SFAS No. 123(R)
resulted in a decrease in reported cash flow from operating activities for the
three and six months ending June 30, 2006 of $2.1 million and $4.6 million,
respectively, offset by an increase in reported cash flow from financing
activities of $2.1 million and $4.6 million, respectively. The Company's
adoption of SFAS No. 123(R) did not effect operating income, income before
income taxes, net income, cash flow from operations, cash flow from financing
activities, basic and diluted net income per share in the comparable second
quarter and six months ended June 30, 2005.

Total compensation cost for stock-based compensation arrangements
recognized in the three and six months ending June 30, 2006, respectively, was
$2.3 million and $4.0 million for stock options and $0.9 million and $1.6
million for restricted stock. Compensation cost recognized in general and
administrative expenses for the three and six months ending June 30, 2006,
respectively, was $2.0 million and $3.5 million for stock options and $0.9
million and $1.5 million for restricted stock. Compensation cost recognized in
cost of goods sold for the three and six months ending June 30, 2006,
respectively, was $0.3 million and $0.5 million for stock options. Compensation
cost recognized in cost of goods sold for six months ending June 30, 2006 was
$0.1 for restricted stock. Recognition of compensation cost was consistent with
recognition of cash compensation for the same employees. The total income tax
benefit recognized in the income statement for the three and six months ending
June 30, 2006 for stock-based compensation arrangements was $0.7 million and
$1.3 million, respectively.

As of June 30, 2006, there was $17.0 million of total unrecognized
compensation cost related to stock options that is expected to be recognized
over a weighted-average period of 1.6 years.

A summary of the Company's stock option activity as of June 30, 2006, and
changes during the six months ended June 30, 2006 is presented in the following
table:

WEIGHTED WEIGHTED-AVERAGE
AVERAGE REMAINING AGGREGATE
FIXED OPTIONS SHARES PRICE CONTRACTUAL TERM INTRINSIC VALUE
- ---------------------------------------------------------------------------------------------------------------

Outstanding at January 1, 2006 4,197,150 $26.57
Granted 541,365 51.14
Exercised (562,887) 22.98
Forfeited/Expired (345,911) 27.02
--------------------------------------------
Outstanding at June 30, 2006 3,829,717 $30.48 7.41 $64,015,675
============================================
Exercisable at June 30, 2006 1,606,904 $23.93 6.24 $37,398,016
============================================

The intrinsic value for stock options outstanding and exercisable is
defined as the difference between the market value of the Company's common stock
as of the end of the period and the grant price. The total intrinsic value of
options exercised during the six months ending June 30, 2006 was $14.9 million.
During the six months ending June 30, 2006, cash received from options exercised
was $13.3 million and the actual tax benefit realized for the tax deductions
from stock options exercised totaled $5.4 million.

-12-

IDEX CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
(IN THOUSANDS EXCEPT PER SHARE AMOUNTS)
(UNAUDITED)

A summary of the Company's restricted stock activity as of June 30, 2006,
and changes during the six months ending June 30, 2006 is presented in the
following table:

WEIGHTED-AVERAGE
GRANT DATE FAIR
RESTRICTED STOCK SHARES VALUE
- --------------------------------------------------------------------------------------

Nonvested at January 1, 2006 296,530 $35.93
Granted 69,310 50.97
Vested (25,000) 40.33
Forfeited (5,450) 40.33
-------
Nonvested at June 30, 2006 335,390 $38.94
=======

Generally, restricted stock grants accrue dividends and their fair value is
equal to the market price of the Company's stock at the date of the grant. As of
June 30, 2006, there was $10.8 million of total unrecognized compensation cost
related to restricted stock that is expected to be recognized over a
weighted-average period of 1.6 years.

11. RETIREMENT BENEFITS

The Company sponsors several qualified and nonqualified defined benefit and
defined contribution pension plans and other postretirement plans for its
employees. The following tables provide the components of net periodic benefit
cost for its major defined benefit plans and its other postretirement plans.

PENSION BENEFITS
------------------------------------------------
SECOND QUARTER ENDED JUNE 30,
2006 2005
---- ----

U.S. NON-U.S. U.S. NON-U.S.
------- -------- -------- --------

Service cost .................... $ 789 $ 165 $ 920 $ 166
Interest cost ................... 1,032 288 858 382
Expected return on plan assets .. (1,208) (183) (1,055) (174)
Net amortization ................ 742 130 548 81
------- ------- ------- -------
Net periodic benefit cost ... $ 1,355 $ 400 $ 1,271 $ 455
======= ======= ======= =======

PENSION BENEFITS
------------------------------------------------
SIX MONTHS ENDED JUNE 30,
2006 2005
---- ----

U.S. NON-U.S. U.S. NON-U.S.
------- -------- -------- --------

Service cost.................... $ 1,533 $ $327 $ 2,132 $ 319
Interest cost .................. 1,977 570 2,092 680
Expected return on plan assets.. (2,417) (365) (2,668) (347)
Net amortization............... 1,367 256 1,301 146
------- ------- ------- -----
Net periodic benefit cost.. $ 2,460 $ 788 $ 2,857 $ 798
======= ======= ======= =====

-13-

IDEX CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
(IN THOUSANDS EXCEPT PER SHARE AMOUNTS)
(UNAUDITED)

OTHER BENEFITS
----------------------------------------------
SECOND QUARTER ENDED SIX MONTHS ENDED
JUNE 30, JUNE 30,
-------- --------
2006 2005 2006 2005
------ ------ ------ -----

Service cost ...................... $ 128 $ 121 $ 237 $ 241
Interest cost ..................... 372 318 692 634
Net amortization .................. 66 19 123 39
------ ------ ------ ------
Net periodic benefit cost ..... $ 566 $ 458 $1,052 $ 914
====== ====== ====== ======

The Company previously disclosed in its financial statements for the year
ended December 31, 2005, that it expected to contribute approximately $6.0
million to these pension plans and $1.0 million to its other postretirement
benefit plans in 2006. As of June 30, 2006, $5.0 million of contributions have
been made to the pension plans and $.6 million has been made to its other
postretirement benefit plans. The Company presently anticipates contributing up
to an additional $1.4 million in 2006 to fund the pension plans and other
postretirement benefit plans.

12. LEGAL PROCEEDINGS

IDEX is a party to various legal proceedings arising in the ordinary course
of business, none of which is expected to have a material adverse effect on its
business, financial condition, results of operations or cash flows.

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
OF OPERATIONS.

CAUTIONARY STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT

The "Historical Overview and Outlook" and the "Liquidity and Capital
Resources" sections of this management's discussion and analysis of our
financial condition and operations contain forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Exchange Act of 1934, as amended. These statements may relate to,
among other things, capital expenditures, cost reductions, cash flow, and
operating improvements and are indicated by words or phrases such as
"anticipate," "estimate," "plans," "expects," "projects," "should," "will,"
"management believes," "the company believes," "we believe," "the company
intends" and similar words or phrases. These statements are subject to inherent
uncertainties and risks that could cause actual results to differ materially
from those anticipated at the date of this filing. The risks and uncertainties
include, but are not limited to, the following: economic and political
consequences resulting from terrorist attacks and wars; levels of industrial
activity and economic conditions in the U.S. and other countries around the
world; pricing pressures and other competitive factors, and levels of capital
spending in certain industries - all of which could have a material impact on
our order rates and results, particularly in light of the low levels of order
backlogs we typically maintain; our ability to make acquisitions and to
integrate and operate acquired businesses on a profitable basis; the
relationship of the U.S. dollar to other currencies and its impact on pricing
and cost competitiveness; political and economic conditions in foreign countries
in which we operate; interest rates; capacity utilization and the effect this
has on costs; labor markets; market conditions and material costs; and
developments with respect to contingencies, such as litigation and environmental
matters. The forward-looking statements included here are only made as of the
date of this report, and we undertake no obligation to publicly update them to
reflect subsequent events or circumstances. Investors are cautioned not to rely
unduly on forward-looking statements when evaluating the information presented
here.

-14-

HISTORICAL OVERVIEW AND OUTLOOK

IDEX Corporation ("IDEX") or the ("Company") is an applied solutions
company specializing in fluid and metering technologies, health and science
technologies, dispensing equipment, and fire, safety and other diversified
products built to its customers' exacting specifications. Its products are sold
in niche markets to a wide range of industries throughout the world.
Accordingly, our businesses are affected by levels of industrial activity and
economic conditions in the U.S. and in other countries where we do business and
by the relationship of the U.S. dollar to other currencies. Levels of capacity
utilization and capital spending in certain industries and overall industrial
activity are among the factors that influence the demand for our products.

The Fluid & Metering Technologies Group produces pumps, compressors, flow
meters, and related controls for the movement of liquids and gases in a diverse
range of end markets from industrial infrastructure to food and beverage. The
Health & Science Technologies Group produces a wide variety of small scale,
highly accurate pumps, valves, fittings and medical devices, as well as
compressors used in medical, dental and industrial applications. The Dispensing
Equipment Group produces highly engineered equipment for dispensing, metering
and mixing colorants, paints, inks and dyes, hair colorants and other personal
care products, as well as refinishing equipment. The Fire & Safety/Diversified
Products Group produces firefighting pumps, rescue tools, lifting bags and other
components and systems for the fire and rescue industry; and engineered
stainless steel banding and clamping devices used in a variety of industrial and
commercial applications.

IDEX has a history of achieving above-average operating margins. Our
operating margins have exceeded the average operating margin for the companies
that comprise the Value Line Composite Index (VLCI) every year since 1988. We
view the VLCI operating performance statistics as a proxy for an average
industrial company. Our operating margins are influenced by, among other things,
utilization of facilities as sales volumes change and inclusion of newly
acquired businesses.

Some of our key 2006 financial highlights for the six months ended June 30,
2006 were as follows:

o Orders were $585.1 million, 12% higher than a year ago; base business
orders -- excluding acquisitions and foreign currency translation -- were
up 10%.
o Sales of $564.0 million rose 11%; base business sales -- excluding
acquisitions and foreign currency translation -- were up 9%.
o Gross margins improved 20 basis points to 41.3% of sales, while operating
margins at 18.2% were 100 basis points higher than a year ago.
o Income from continuing operations increased 23% to $63.7 million.
o Diluted EPS from continuing operations of $1.18 was 19 cents ahead of the
same period 2005.
o Net income increased 24% to $65.0 million.
o Diluted EPS of $1.21 was 21 cents ahead of the same period of 2005.

Our business units continue to deliver profitable sales growth as a result
of new technology initiatives and market initiatives and our on-going commitment
to operational excellence. During the first six months of the year, organic
sales growth was 9 percent, reflecting particular strength in Health & Science
Technologies at 17 percent, Fluid & Metering Technologies at 10 percent and Fire
& Safety/ Diversified Products at 9 percent. Within Dispensing Equipment, we
continue to experience strong demand in North America and less-than-favorable
market conditions in Europe. As we move forward, our businesses are well
positioned in attractive product segments driven by strong underlying industry
segment fundamentals and, even more importantly, our ability to effectively
serve expanding niche applications. We are focused on the voice of our customer,
while using the powerful combination of continuous process improvement and new
product innovation to drive our future performance.

The following forward-looking statements are qualified by the cautionary
statement under the Private Securities Litigation Reform Act set forth above.

-15-

As a short-cycle business, our performance is reliant upon the current pace
of incoming orders, and we have limited visibility on future business
conditions. We believe IDEX is well positioned for earnings expansion. This is
based on our lower cost structure resulting from our operational excellence
discipline, our investment in new products, applications and global markets, and
our pursuit of strategic acquisitions to help drive IDEX's longer term
profitable growth.

RESULTS OF OPERATIONS

For purposes of this discussion and analysis section, reference is made to
the table on the following page and the Company's Consolidated Statements of
Operations included in Item 1. During the second quarter, the Company determined
that Lubriquip, its lubricant dispensing business, met the criteria to be
classified as a discontinued operation. The financial statements and the group
financial information have been reclassified to reflect Lubriquip as a
discontinued operation.

Performance in the Three Months Ended June 30, 2006 Compared with the Same
Period of 2005

For the three months ended June 30, 2006, orders, sales and profits were
higher than the comparable three months of last year. New orders totaled $290.5
million, 10% higher than the same period last year. Excluding the impact of
foreign currency translation and the three acquisitions made since the beginning
of 2006 (Airshore- January 2006; JUN-AIR - February 2006 and EPI - May 2006),
base business orders were 5% higher than the same period one year ago.

Sales in the three months ended June 30, 2006 were $297.2 million, a 12%
improvement from the comparable period last year. Base business shipments grew
7% while acquisitions accounted for a 5% increase. Sales to international
customers from base businesses represented approximately 46% of total sales in
the current period, compared with 45% in the year-ago quarter.

During the quarter, Fluid & Metering Technologies contributed 36% of sales
and 33% of operating income; Health & Science Technologies accounted for 27% of
sales and 23% of operating income; Dispensing Equipment accounted for 15% of
sales and 18% of operating income; and Fire & Safety/Diversified Products
represented 22% of sales and 26% of operating income.

Fluid & Metering Technologies Group sales of $108.4 million for the three
months ended June 30, 2006 rose $9.6 million, or 10% compared with 2005,
reflecting 9% base business growth and a 1% favorable impact from foreign
currency translation. In the second quarter of 2006, base business sales grew
approximately 9% domestically and 12% internationally. Base business sales to
customers outside the U.S. were approximately 43% of total group sales during
the second quarter of 2006 compared with 42% in the comparable quarter of 2005.

Health & Science Technologies Group sales of $81.3 million increased $21.8
million, or 37%, in the second quarter of 2006 compared with last year's second
quarter. This increase was attributed to the JUN-AIR and EPI acquisitions which
contributed 23% to the increase and an increase in base business volume of 14%.
In the second quarter of 2006, base business sales increased 7% domestically and
36% internationally. Base business sales to customers outside the U.S. were
approximately 36% of total group sales in the second quarter of 2006, compared
with 31% in the comparable quarter of 2005.

Dispensing Equipment Group sales of $44.4 million decreased $1.9 million,
or 4%, in the second quarter of 2006 compared with 2005. This decrease reflects
a 4% decrease in base business volume. In the second quarter of 2006, base
business sales increased 10% domestically, but decreased 7% internationally.
Base business sales to customers outside the U.S. were approximately 66% of
total group sales in the second quarter of 2006, compared with 70% in the
comparable quarter of 2005.

Fire & Safety/Diversified Products Group sales of $64.6 million increased
$3.4 million, or 5%, in the second quarter of 2006 compared with 2005. This
increase reflects a 5% increase in base business volume. In the second quarter
of 2006, base business sales increased 8% domestically and 2% internationally.
Base business sales to customers outside the U.S. were approximately 45% of
total group sales in the second quarter of 2006, compared with 46% in the
comparable quarter of 2005.

-16-

SECOND QUARTER SIX MONTHS
ENDED JUNE 30, ENDED JUNE 30,
-------------- --------------
2006 (1) 2005 2006 (1) 2005
----------- --------- ----------- ---------

Fluid & Metering Technologies
Net sales .............................. $108,437 $ 98,793 $210,836 $192,264
Operating income (2) ................... 21,275 18,244 40,519 33,522
Operating margin ....................... 19.6% 18.5% 19.2% 17.4%

Depreciation and amortization .......... $ 2,530 $ 2,551 $ 4,786 $ 5,163
Capital expenditures ................... 1,103 2,542 2,235 5,046
Health & Science Technologies
Net sales .............................. $ 81,299 $ 59,541 $144,320 $112,462
Operating income (2) ................... 14,513 10,115 26,793 19,117
Operating margin ....................... 17.9% 17.0% 18.6% 17.0%

Depreciation and amortization .......... $ 2,444 $ 1,513 $ 3,843 $ 3,033
Capital expenditures ................... 1,506 1,571 2,383 2,657
Dispensing Equipment
Net sales .............................. $ 44,415 $ 46,308 $ 85,823 $ 90,715
Operating income (2) ................... 11,689 12,870 22,019 23,943
Operating margin ....................... 26.3% 27.8% 25.7% 26.4%

Depreciation and amortization .......... $ 1,052 $ 1,088 $ 2,065 $ 2,178
Capital expenditures ................... 531 835 1,190 1,672
Fire & Safety/Diversified Products
Net sales .............................. $ 64,551 $ 61,199 $125,767 $116,771
Operating income (2) ................... 16,266 13,964 29,921 25,502
Operating margin ....................... 25.2% 22.8% 23.8% 21.8%

Depreciation and amortization .......... $ 1,540 $ 1,489 $ 3,078 $ 3,057
Capital expenditures ................... 1,628 997 2,766 1,790
Company
Net sales .............................. $297,169 $264,949 $564,036 $510,087
Operating income ....................... 55,613 47,590 102,876 87,685
Operating margin ....................... 18.7% 18.0% 18.2% 17.2%

Depreciation and amortization (3) ...... $ 7,825 $ 6,792 $ 14,141 $ 13,734
Capital expenditures ................... 5,688 6,100 9,703 11,702

(1) Second quarter and six month data includes acquisition of JUN-AIR and EPI
in the Health & Sciences Technologies Group and Airshore in the Fire &
Safety/Diversified Products Group from the dates of acquisition.
(2) Group operating income excludes unallocated corporate operating expenses.
(3) Excludes amortization of debt issuance expenses and unearned stock
compensation.

Gross profit of $123.0 million, in the second quarter of 2006, increased $13.4
million, or 12%, from 2005. Gross profit as a percent of sales was 41.4% in both
the second quarter of 2006 and 2005. Volume leverage, coupled with the Company's
strategic sourcing and other operational excellence initiatives, was offset by
product mix and the impact of acquisitions.

Selling, general and administrative (SG&A) expenses increased to $67.4 million
in the second quarter of 2006 from $62.0 million in 2005 primarily due to higher
volume, the acquisitions of Airshore JUN-AIR and EPI, and the implementation of
Statement of Financial Accounting Standard ("SFAS") No. 123(R), "Share-Based
Payment". As a percent of sales, SG&A expenses were 22.7%, an improvement from
23.4% in 2005.

-17-

Operating income increased $8.0 million, or 17%, to $55.6 in the second
quarter of 2006 from $47.6 million in 2005, primarily reflecting higher volumes,
partially offset by increased SG&A expenses. Second quarter operating margins
were 18.7% of sales, 70 basis points higher than the second quarter of 2005. The
improvement from last year resulted from a 70 basis point decrease in SG&A as a
percent of sales. In the Fluid & Metering Technologies Group, operating income
of $21.3 million and operating margins of 19.6% in the second quarter of 2006
were up from the $18.2 million and 18.5% recorded in 2005 principally due to
volume leverage and the impact of our operational excellence initiatives.
Operating income for the Health & Science Technologies Group of $14.5 million
was up from the $10.1 million recorded in 2005 principally due to volume
leverage. Operating margins within Health & Science Technologies Group of 17.9%
in the current quarter were up from 17.0% in 2005 primarily due to savings
realized from the Company's operational excellence initiatives. Operating income
for the Dispensing Equipment Group of $11.7 million was down from the $12.9
million recorded in 2005 mainly due to unfavorable market conditions in Europe.
Operating margins within Dispensing Equipment Group of 26.3% in the current
quarter were down from 27.8% in 2005 primarily due to volume and product mix.
Operating income in the Fire & Safety/Diversified Products Group of $16.3
million and operating margins of 25.2% in the current quarter increased from
$14.0 million and 22.8% achieved in 2005 and primarily reflected increased sales
volume and the impact of operational excellence initiatives.

Interest expense increased to $4.1 million in the current quarter from $3.8
million in the second quarter of 2005, principally due to higher debt levels.

IDEX's provision for income taxes is based upon estimated annual tax rates
for the year applied to federal, state and foreign income. The provision for
income taxes increased to $17.4 million in the second quarter of 2006 from $15.4
million in 2005. The effective tax rate decreased to 33.6% in the current
quarter from 35.0% in the second quarter of 2005 due to changes in the mix of
global pre-tax income among taxing jurisdictions, partially offset by the
expiration of the research and development tax credits in 2006.

Income from continuing operations for the current quarter was $34.4
million, 20% higher than the $28.6 million earned in the second quarter of 2005.
Diluted earnings per share from continuing operations in the second quarter of
2006 of $.64 increased $.10, or 19%, compared with the second quarter of 2005.

Net income for the current quarter was $35.0 million, 21% higher than the
$28.9 million earned in the second quarter of 2005. Diluted earnings per share
in the second quarter of 2006 of $.65, which included one cent from discontinued
operations, increased $.10, or 18%, compared with the second quarter of 2005.

Performance in the Six Months Ended June 30, 2006 Compared with the Same Period
of 2005

Orders, sales and profits were higher for the first six months of 2006
compared with the same period last year. New orders for the first six months of
2006 totaled $585.1 million, 12% higher than last year. Excluding the impact of
foreign currency translation and the three acquisitions made since the beginning
of 2006 (Airshore, JUN-AIR and EPI), orders were 10% higher than the comparable
period of 2005.

Sales in the first six months of the year increased 11% to $564.0 million
from $510.1 million a year ago. Base business sales rose 9%, acquisitions
accounted for a 3% improvement and foreign currency translation negatively
impacted sales by 1%. For the first six months of the year, base business sales
to international customers were approximately 45% of total sales for both 2006
and 2005.

For the first six months, Fluid & Metering Technologies contributed 37
percent of sales and 34 percent of operating income; Health & Science
Technologies accounted for 26 percent of sales and 23 percent of operating
income; Dispensing Equipment accounted for 15 percent of sales and 18 percent of
operating income; and Fire & Safety/Diversified Products represented 22 percent
of sales and 25 percent of operating income.

-18-

Fluid & Metering Technologies Group sales of $210.8 million increased $18.6
million, or 10%, for the six months ended June 30, 2006 compared with 2005. The
10% increase reflects all base business sales as foreign currency translation
had little impact. In the first six months of 2006, base business sales grew 10%
domestically and 9% internationally. Base business sales to customers outside
the U.S. were approximately 42% of total group sales in both the 2006 and 2005
periods.

Health & Science Technologies Group sales of $144.3 million increased $31.9
million, or 28%, for the first six months ended June 30, 2006 compared with
2005. This reflected a 17% increase in base business volume and an 11% increase
from the JUN-AIR and EPI acquisitions. In the first six months of 2006, base
business sales increased 10% domestically and 33% internationally. Base business
sales to customers outside the U.S. were approximately 35% of total group sales
in the first six months of 2006, compared with 31% in the comparable period of
2005.

Dispensing Equipment Group sales of $85.8 million decreased $4.9 million,
or 5%, in the first six months of 2006 compared with the same period in 2005.
The decrease was attributable to a decrease in base business sales of 3% and
unfavorable foreign currency translation of 2%. In the first six months of 2006,
base business sales increased 8% domestically, but decreased 7% internationally.
Base business sales to customers outside the U.S. were approximately 66% of
total group sales in the first six months of 2006, compared with 69% in the
comparable period of 2005.

Fire & Safety/Diversified Group sales of $125.8 million increased $9.0
million, or 8%, in the first six months of 2006 compared with 2005. This
reflected a 9% increase in base business volume and a 1% decrease from foreign
currency translation. In the first six months of 2006, base business sales
increased 11% domestically and 8% internationally. Base business sales to
customers outside the U.S. were approximately 46% of total group sales in both
the 2006 and 2005 periods.

Gross profit of $233.1 million in the first six months of 2006 increased
$23.7 million, or 11% from 2005. Gross profit as a percent of sales was 41.3% in
2006, an increase from 41.1% in 2005. The improved gross margins primarily
reflected the Company's strategic sourcing and other operational excellence
initiatives.

SG&A increased to $130.3 million in 2006 from $121.7 million in 2005, and
as a percent of sales was 23.1%, an improvement from 23.9% in 2005. The increase
in SG&A expenses reflected the acquisitions of Airshore, JUN-AIR and EPI,
volume-related expenses and the implementation of SFAS No. 123(R).

Operating income increased by $15.2 million, or 17%, to $102.9 million in
the first six months of 2006 from $87.7 million in 2005, primarily reflecting
the higher gross margins discussed above, partially offset by increased SG&A
expenses. Operating margins for the first six months of 2006 were 18.2% compared
with 17.2% in the prior year period. The margin increase from last year was
primarily due to volume leverage and the improvement in gross margins discussed
above. In the Fluid & Metering Technologies Group, operating income of $40.5
million and operating margins of 19.2% in 2006 were up from the $33.5 million
and 17.4% recorded in 2005, principally due to volume leverage and the impact of
our operational excellence initiatives. Operating income for the Health &
Science Technologies Group of $26.8 million and operating margins of 18.6% were
up from the $19.1 million and 17.0% in 2005 principally due to volume leverage
and savings realized from the Company's operational excellence initiatives.
Operating income for the Dispensing Equipment Group of $22.0 million and
operating margins of 25.7% in 2006 were down from the $23.9 million and 26.4% in
2005, mainly due to unfavorable market conditions in Europe. Operating income in
the Fire & Safety/Diversified Products Group of $29.9 million and operating
margins of 23.8% in 2006 increased from $25.5 million and 21.8% achieved in 2005
and primarily reflected increased sales volume and the impact of operational
excellence initiatives.

Interest expense decreased to $7.0 million in the first six months of 2006
from $7.7 million in 2005. This decrease was principally due to lower debt
levels.

IDEX's provision for income taxes is based upon estimated annual tax rates
for the year applied to federal, state and foreign income. The provision for
income taxes increased to $32.4 million in 2006 from $28.5 million in 2005. The
effective tax rate decreased to 33.7% in 2006 from 35.4% in 2005 due to changes
in the mix of global pre-tax income among taxing jurisdictions, partially offset
by the expiration of the research and development tax credits in 2006.

-19-

Income from continuing operations for the first six months of 2006 was
$63.7 million, 23% higher than the $51.9 million earned in the same period of
2005. Diluted earnings per share from continuing operations in the first six
months of 2006 of $1.18 increased $0.19, or 19%, compared with the same period
of 2005.

Net income for the first six months of 2006 was $65.0 million, 24% higher
than the $52.6 million earned in the same period of 2005. Diluted earnings per
share in the first six months of 2006 of $1.21, which included three cents from
discontinued operations, increased $0.21, or 21%, compared with the same period
last year.

LIQUIDITY AND CAPITAL RESOURCES

At June 30, 2006, working capital was $178.6 million and our current ratio
was 1.9 to 1. Cash flows from operating activities increased $16.5 million, or
32%, to $68.2 million in the first six months of 2006 mainly due to the improved
operating results discussed above.

Cash flows provided from operations were more than adequate to fund capital
expenditures of $9.7 million and $11.7 million in the first six months of 2006
and 2005, respectively. Capital expenditures were generally for machinery and
equipment that improved productivity and tooling to support IDEX's global
sourcing initiatives, although a portion was for business system technology and
replacement of equipment and facilities. Management believes that IDEX has ample
capacity in its plants and equipment to meet expected needs for future growth in
the intermediate term.

The Company acquired Airshore in January 2006 for cash consideration of
$12.6 million, JUN-AIR in February 2006 for cash consideration of $15.3 million
and the assumption of approximately $7.1 million in debt and EPI in May 2006 for
cash consideration of $92.3 million.

In addition to the $150.0 million of 6.875% Senior Notes due February 15,
2008, the Company also has a $600.0 million domestic multi-currency bank
revolving credit facility ("Credit Facility"), which expires December 14, 2009.
With $29.0 million of borrowings outstanding under the facility at June 30,
2006, and outstanding letters of credit totaling $5.3 million, the maximum
amount available under the Credit Facility was $565.7 million. The Credit
Facility contains a covenant that limits total debt outstanding to 3.25 times
operating cash flow, as defined in the agreement. Our total debt outstanding was
$198.8 million at June 30, 2006, and based on the covenant, total debt
outstanding was limited to $755.3 million. Interest is payable quarterly on the
outstanding balance at the bank agent's reference rate or, at the Company's
election, at LIBOR plus an applicable margin. The applicable margin is based on
the credit rating of our Senior Notes, and can range from 27 basis points to 75
basis points. Based on the Company's BBB rating at June 30, 2006, the applicable
margin was 55 basis points. We also pay an annual fee of 15 basis points on the
total Credit Facility.

We also have a one-year, renewable $30.0 million demand line of credit
("Short-Term Facility"), which expires on December 12, 2006. Borrowings under
the Short-Term Facility are at LIBOR plus the applicable margin in effect under
the Credit Facility. At June 30, 2006, there were no borrowings outstanding
under this facility.

We believe the Company will generate sufficient cash flow from operations
for the next 12 months and in the long term to meet its operating requirements,
interest on all borrowings, required debt repayments, any authorized share
repurchases, planned capital expenditures, and annual dividend payments to
holders of common stock. In the event that suitable businesses are available for
acquisition upon terms acceptable to the Board of Directors, we may obtain all
or a portion of the financing for the acquisitions through the incurrence of
additional long-term borrowings.

Our contractual obligations and commercial commitments include rental
payments under operating leases, payments under capital leases, and other
long-term obligations arising in the ordinary course of business. There are no
identifiable events or uncertainties, including the lowering of our credit
rating that would accelerate payment or maturity of any of these commitments or
obligations.

-20-

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

The Company is subject to market risk associated with changes in interest
rates and foreign currency exchange rates. Interest rate exposure is limited to
the $198.8 million of total debt outstanding at June 30, 2006. Approximately 25%
of the debt is priced at interest rates that float with the market. A 50-basis
point movement in the interest rate on the floating rate debt would result in an
approximate $0.2 million annualized increase or decrease in interest expense and
cash flows. The remaining debt is fixed rate debt. We will, from time to time,
enter into interest rate swaps on our debt when we believe there is a financial
advantage for doing so. A treasury risk management policy, adopted by the Board
of Directors, describes the procedures and controls over derivative financial
and commodity instruments, including interest rate swaps. Under the policy, we
do not use derivative financial or commodity instruments for trading purposes,
and the use of these instruments is subject to strict approvals by senior
officers. Typically, the use of derivative instruments is limited to interest
rate swaps on the Company's outstanding long-term debt. As of June 30, 2006, the
Company did not have any derivative instruments outstanding.

Our foreign currency exchange rate risk is limited principally to the euro
and British pound. We manage our foreign exchange risk principally through
invoicing our customers in the same currency as the source of our products. As a
result, the Company's exposure to any movement in foreign currency exchange
rates is immaterial to the Consolidated Statements of Operations.

ITEM 4. CONTROLS AND PROCEDURES.

The Company maintains disclosure controls and procedures that are designed
to ensure that information required to be disclosed in the Company's Exchange
Act reports is recorded, processed, summarized and reported within the time
periods specified in the SEC's rules and forms, and that such information is
accumulated and communicated to the Company's management, including its Chief
Executive Officer and Chief Financial Officer, as appropriate, to allow timely
decisions regarding required disclosure. In designing and evaluating the
disclosure controls and procedures, management recognized that any controls and
procedures, no matter how well designed and operated, can provide only
reasonable assurance of achieving the desired control objectives, and management
is required to apply its judgment in evaluating the cost-benefit relationship of
possible controls and procedures.

As required by SEC Rule 13a-15(b), the Company carried out an evaluation,
under the supervision and with the participation of the Company's management,
including the Company's Chief Executive Officer and the Company's Chief
Financial Officer, of the effectiveness of the design and operation of the
Company's disclosure controls and procedures as of the end of the period covered
by this report. Based on the foregoing, the Company's Chief Executive Officer
and Chief Financial Officer concluded that the Company's disclosure controls and
procedures were effective.

There has been no change in the Company's internal controls over financial
reporting during the Company's most recent fiscal quarter that has materially
affected, or is reasonably likely to materially affect, the Company's internal
controls over financial reporting.

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS.

IDEX and five of its subsidiaries have been named as defendants in a number
of lawsuits claiming various asbestos-related personal injuries, allegedly as a
result of exposure to products manufactured with components that contained
asbestos. Such components were acquired from third party suppliers, and were not
manufactured by any of the subsidiaries. To date, all of the Company's
settlements and legal costs, except for costs of coordination, administration,
insurance investigation and a portion of defense costs, have been covered in
full by insurance subject to applicable deductibles. However, the Company cannot
predict whether and to what extent insurance will be available to continue to
cover such settlements and legal costs, or how insurers may respond to claims
that are tendered to them.

-21-

Claims have been filed in Alabama, California, Connecticut, Delaware,
Georgia, Illinois, Louisiana, Maryland, Massachusetts, Michigan, Minnesota,
Mississippi, Missouri, Nevada, New Jersey, New York, Ohio, Oklahoma, Oregon,
Pennsylvania, Rhode Island, Texas, Utah, Virginia, Washington and Wyoming. Most
of the claims resolved to date have been dismissed without payment. The balance
have been settled for reasonable amounts. Only one case has been tried,
resulting in a verdict for the Company's business unit.

No provision has been made in the financial statements of the Company,
other than for insurance deductibles in the ordinary course, and IDEX does not
currently believe the asbestos-related claims will have a material adverse
effect on the Company's business or financial position.

IDEX is also party to various other legal proceedings arising in the
ordinary course of business, none of which is expected to have a material
adverse effect on its business, financial condition or results of operations.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

Total Number of Maximum Number of
Shares Purchased as Shares that May Yet
Part of Publicly be Purchased Under
Total Number of Average Price Announced Plans the Plans
Period Shares Purchased Paid per Share or Programs (1) or Programs (1)
------ ---------------- -------------- --------------- -----------------

April 1, 2006 to
April 30, 2006 - - - 2,240,250
May 1, 2006 to
May 31, 2006 - - - 2,240,250
June 1, 2006 to
June 30, 2006 - - - 2,240,250

(1) On October 20, 1998, IDEX's Board of Directors authorized the
repurchase of up to 2.25 million shares of its common stock, either at market
prices or on a negotiated basis as market conditions warrant.

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.

The Company held its Annual Shareholders' Meeting on Tuesday, April 4, 2006
and voted on two matters. The first matter was the election of two directors to
serve a three-year term on the Board of Directors of IDEX Corporation. The
following persons received a plurality of votes cast for Class II directors.

Director For Withheld Broker Non-Votes
- -------- ---------- -------- ----------------

Michael T. Tokarz 50,793,275 483,466 0
Frank S. Hermance 51,158,944 117,977 0

Secondly, shareholders voted on a proposal to appoint Deloitte & Touche LLP
as auditors. The proposal received a majority of the votes cast as follows:

Affirmative votes 50,720,437
Negative votes 554,618
Abstentions 1,686
Broker non-votes 0

-22-

ITEM 5. OTHER INFORMATION.

There has been no material change to the procedures by which security
holders may recommend nominees to the Company's board.

ITEM 6. EXHIBITS.

The exhibits listed in the accompanying "Exhibit Index" are filed as part
of this report.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.

IDEX CORPORATION

August 8, 2006 /s/ Dominic A. Romeo
------------------------------------
Dominic A. Romeo
Vice President and Chief Financial
Officer
(duly authorized principal financial
officer)

-23-

EXHIBIT INDEX

EXHIBIT
NUMBER DESCRIPTION
- -------- -----------

3.1 Restated Certificate of Incorporation of IDEX Corporation (formerly
HI, Inc.) (incorporated by reference to Exhibit No. 3.1 to the
Registration Statement on Form S-1 of IDEX, et al., Registration No.
33-21205, as filed on April 21, 1988)

3.1(a) Amendment to Restated Certificate of Incorporation of IDEX Corporation
(formerly HI, Inc.), (incorporated by reference to Exhibit No. 3.1(a)
to the Quarterly Report of IDEX on Form 10-Q for the quarter ended
March 31, 1996, Commission File No. 1-10235)

3.1(b) Amendment to Restated Certificate of Incorporation of IDEX Corporation
(incorporated by reference to Exhibit No. 3.1 (b) to the Current
Report of IDEX on Form 8-K dated March 24, 2005, Commission File
No. 1-10235)

3.2 Amended and Restated By-Laws of IDEX Corporation (incorporated by
reference to Exhibit No. 3.2 to Post-Effective Amendment No. 2 to the
Registration Statement on Form S-1 of IDEX, et al., Registration No.
33-21205, as filed on July 17, 1989)

3.2(a) Amended and Restated Article III, Section 13 of the Amended and
Restated By-Laws of IDEX Corporation (incorporated by reference to
Exhibit No. 3.2(a) to Post-Effective Amendment No. 3 to the
Registration Statement on Form S-1 of IDEX, et al., Registration No.
33-21205, as filed on February 12, 1990)

4.1 Restated Certificate of Incorporation and By-Laws of IDEX Corporation
(filed as Exhibits No. 3.1 through 3.2 (a))

4.2 Indenture, dated as of February 23, 1998, between IDEX Corporation,
and Norwest Bank Minnesota, National Association, as Trustee, relating
to the 6-7/8% Senior Notes of IDEX Corporation due February 15, 2008
(incorporated by reference to Exhibit No. 4.1 to the Current Report of
IDEX on Form 8-K dated February 23, 1998, Commission File No. 1-10235)

4.3 Specimen Senior Note of IDEX Corporation (incorporated by reference to
Exhibit No. 4.1 to the Current Report of IDEX on Form 8-K dated
February 23, 1998, Commission File No. 1-10235)

4.4 Specimen Certificate of Common Stock of IDEX Corporation (incorporated
by reference to Exhibit No. 4.3 to the Registration Statement on Form
S-2 of IDEX, et al., Registration No. 33-42208, as filed on September
16, 1991)

4.5 Credit Agreement, dated as of December 14, 2004, among IDEX
Corporation, Bank of America N.A. as Agent and Issuing Bank, and the
Other Financial Institutions Party Hereto (incorporated by reference
to Exhibit No. 4.5 to the Annual Report of IDEX on Form 10-K for the
year ended December 31, 2004, Commission File No. 1-10235)

4.6 Credit Lyonnais Uncommitted Line of Credit, dated as of December 3,
2001 (incorporated by reference to Exhibit 4.6 to the Annual Report of
IDEX on Form 10-K for the year ended December 31, 2001, Commission
File No. 1-10235)

4.6(a) Amendment No. 6 dated as of December 14, 2005 to the Credit
Lyonnais Uncommitted Line of Credit Agreement dated December 3, 2001

*31.1 Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) or
Rule 15d-14(a)

*31.2 Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) or
Rule 15d-14(a)

*32.1 Certification pursuant to Section 1350 of Chapter 63 of Title 18 of
the United States Code

*32.2 Certification pursuant to Section 1350 of Chapter 63 of Title 18 of
the United States Code
</Table>

- --------------

* Filed herewith

-24-